Q2 2019 Earnings Estimate for HCA Healthcare Inc (NYSE:HCA) Issued By Jefferies Financial Group

HCA Healthcare Inc (NYSE:HCA) – Analysts at Jefferies Financial Group cut their Q2 2019 earnings per share estimates for HCA Healthcare in a note issued to investors on Tuesday, April 30th, Zacks Investment Research reports. Jefferies Financial Group analyst B. Tanquilut now anticipates that the company will post earnings of $2.54 per share for the quarter, down from their previous estimate of $2.56. Jefferies Financial Group currently has a “Buy” rating and a $158.00 price target on the stock. Jefferies Financial Group also issued estimates for HCA Healthcare’s Q3 2019 earnings at $2.03 EPS, Q4 2019 earnings at $2.96 EPS, FY2019 earnings at $10.50 EPS and FY2020 earnings at $11.50 EPS.

HCA has been the subject of a number of other research reports. SunTrust Banks raised their price objective on HCA Healthcare to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, January 30th. Raymond James upgraded HCA Healthcare from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $115.00 to $135.00 in a research report on Tuesday, April 23rd. Oppenheimer raised their price objective on HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 30th. Leerink Swann raised their price objective on HCA Healthcare from $160.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 30th. Finally, UBS Group raised their price objective on HCA Healthcare from $164.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and nineteen have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $149.41.

NYSE:HCA traded up $0.81 during mid-day trading on Thursday, hitting $123.51. 1,198,211 shares of the company’s stock traded hands, compared to its average volume of 1,809,590. HCA Healthcare has a 12 month low of $101.30 and a 12 month high of $147.42. The company has a market cap of $42.17 billion, a price-to-earnings ratio of 12.64, a PEG ratio of 0.99 and a beta of 0.75.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share for the quarter, beating the consensus estimate of $2.31 by $0.66. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The firm had revenue of $12.52 billion during the quarter, compared to the consensus estimate of $12.34 billion. During the same quarter in the prior year, the company earned $3.18 EPS. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year.

The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 3rd will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.30%. HCA Healthcare’s payout ratio is presently 16.38%.

In other news, insider Jon M. Foster sold 44,281 shares of the stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $122.28, for a total value of $5,414,680.68. Following the completion of the transaction, the insider now directly owns 96,052 shares of the company’s stock, valued at approximately $11,745,238.56. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 2.70% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare during the 4th quarter valued at $25,000. Sontag Advisory LLC bought a new position in HCA Healthcare in the 4th quarter valued at $26,000. Moody National Bank Trust Division bought a new position in HCA Healthcare in the 4th quarter valued at $27,000. Doyle Wealth Management bought a new position in HCA Healthcare in the 4th quarter valued at $31,000. Finally, Kore Private Wealth LLC bought a new position in HCA Healthcare in the 1st quarter valued at $33,000. 71.66% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Cryptocurrencies

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.